论文部分内容阅读
结核病是严重危及全球的公共卫生问题之一,据WHO统计目前全球约有20亿例受结核分支杆菌感染,其中5000万例感染了耐药结核分支杆菌,使耐药结核病例数明显增多,结核病患者又有发生自然耐药的危险。因此全球的结病耐药趋势严峻,目前耐药、流动人口和人类免疫缺陷病毒(HIV)感染已经成为当今结核病控制所面临的三大难题,其中耐药性是我国结核病控制起主要限制性作用的因素。耐药性的泛滥将会使结核病控制返回无化疗时代。我国结核病耐药情况严重,抗结核治疗不规范及患者依从性差是影响耐药性产生的主要因素。耐药结核病已经成为我国结核病控制的一大难题,若不能有效遏制耐药结核分枝
Tuberculosis is one of the serious public health problems that endanger the world. According to the WHO statistics, there are currently about 2 billion cases of Mycobacterium tuberculosis infection in the world, of which 50 million cases are infected with Mycobacterium tuberculosis, resulting in a marked increase in the number of drug-resistant TB cases. Tuberculosis Patients have the risk of natural resistance. Therefore, the global trend of resistance to tuberculosis is grim. At present, drug-resistant, floating population and human immunodeficiency virus (HIV) infection have become the three major problems in today’s tuberculosis control. Drug resistance is the main restrictive effect of TB control in our country the elements of. The proliferation of resistance will return tuberculosis control to a chemotherapy-free age. Tuberculosis resistance in China is serious, anti-TB treatment is not standardized and poor compliance is the main factor affecting the drug resistance. Drug-resistant tuberculosis has become a major problem of tuberculosis control in our country. If it can not effectively stop the drug-resistant tuberculosis branch